These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important. Laher F, Salami T, Hornschuh S, Makhale LM, Khunwane M, Andrasik MP, Gray GE, Van Tieu H, Dietrich JJ. BMC Public Health; 2020 Nov 07; 20(1):1669. PubMed ID: 33160341 [Abstract] [Full Text] [Related]
26. Oral and vaginal HIV pre-exposure prophylaxis product attribute preferences among female sex workers in the Mexico-US border region. Pines HA, Strathdee SA, Hendrix CW, Bristow CC, Harvey-Vera A, Magis-Rodríguez C, Martinez G, Semple SJ, Patterson TL. Int J STD AIDS; 2019 Jan 07; 30(1):45-55. PubMed ID: 30170533 [Abstract] [Full Text] [Related]
28. Understanding women and men's acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa. Govender E, Abdool Karim Q. AIDS Care; 2018 Oct 07; 30(10):1311-1314. PubMed ID: 29914270 [Abstract] [Full Text] [Related]
29. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis. Hugo JM, Stall RD, Rebe K, Egan JE, De Swardt G, Struthers H, McIntyre JA. AIDS Behav; 2016 Dec 07; 20(Suppl 3):357-364. PubMed ID: 27631366 [Abstract] [Full Text] [Related]
30. Assessing knowledge, acceptability and social implications of a peer-to-peer HIV self-testing kit distribution model among adolescents aged 15-24 in Zambia and Uganda-HISTAZU: a mixed-method study protocol. Ssemata AS, Bwalya C, Muhumuza R, Ndekezi D, Mbewe M, Simwinga M, Bond V, Seeley J. BMJ Open; 2022 May 27; 12(5):e059340. PubMed ID: 35623747 [Abstract] [Full Text] [Related]
32. The Invisible Product: Preferences for Sustained-Release, Long-Acting Pre-exposure Prophylaxis to HIV Among South African Youth. Montgomery ET, Atujuna M, Krogstad E, Hartmann M, Ndwayana S, OʼRourke S, Bekker LG, van der Straten A, Minnis AM. J Acquir Immune Defic Syndr; 2019 Apr 15; 80(5):542-550. PubMed ID: 30865050 [Abstract] [Full Text] [Related]
35. Acceptability of Three Novel HIV Prevention Methods Among Young Male and Transgender Female Sex Workers in Puerto Rico. Giguere R, Frasca T, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A. AIDS Behav; 2016 Oct 15; 20(10):2192-2202. PubMed ID: 27048236 [Abstract] [Full Text] [Related]
36. How can we help adolescent girls avoid HIV infection? Helitzer-allen D, Makhambera M. Netw Res Triangle Park N C; 1993 May 15; 13(4):7. PubMed ID: 12344880 [Abstract] [Full Text] [Related]
38. Understanding HIV-positive patients' preferences for healthcare services: a protocol for a discrete choice experiment. Youssef E, Cooper V, Miners A, Llewellyn C, Pollard A, Lagarde M, Sachikonye M, Sabin C, Foreman C, Perry N, Nixon E, Fisher M. BMJ Open; 2016 Jul 18; 6(7):e008549. PubMed ID: 27431895 [Abstract] [Full Text] [Related]
40. Designing PrEP and early HIV treatment interventions for implementation among female sex workers in South Africa: developing and learning from a formative research process. Eakle R, Mutanha N, Mbogua J, Sibanyoni M, Bourne A, Gomez G, Venter F, Rees H. BMJ Open; 2018 Jun 14; 8(6):e019292. PubMed ID: 29903784 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]